C12N 2501/2318
Interleukin-18
Official title: Interleukin-18 (IL-18)
C12N2501/2318 (Interleukin-18) appears on 38 US grants and 145 published applications in this corpus.
Search patents in C12N- Granted patents
- 38
- Published applications
- 145
- Assignees
- 94
- Inventors
- 357
- Latest grant
- 31 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2010 | 1 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 0 | 1 |
| 2016 | 0 | 0 |
| 2017 | 0 | 1 |
| 2018 | 0 | 5 |
| 2019 | 1 | 11 |
| 2020 | 1 | 7 |
| 2021 | 3 | 21 |
| 2022 | 1 | 17 |
| 2023 | 8 | 21 |
| 2024 | 10 | 22 |
| 2025 | 11 | 25 |
| 2026 | 2 | 12 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Methods for the simultaneous expansion of multiple immune cell types, related compositions and uses of same in cancer immunotherapy31 Mar 2026US 12,590,148 B2Nkarta, Inc.
- Immune cell function17 Feb 2026US 12,551,530 B2Kite Pharma, Inc.
- Method for producing memory-like NK cells with ability to express higher levels of NCRs, cytotoxicity, and IFN-γ than NK cells in human peripheral blood2 Dec 2025US 12,486,492 B2Korea Research Institute of Bioscience
- Multi-chain chimeric polypeptides and uses thereof25 Nov 2025US 12,479,899 B2ImmunityBio, Inc.
- Methods for activation and expansion of natural killer cells and uses thereof18 Nov 2025US 12,473,336 B2Board of Regents, The University of Texas System
- Method for selecting nk cell donor source20 Aug 2026US 2026/0242734 A1Encell Co., Ltd.
- Cancer-killing cells23 Jul 2026US 2026/0207663 A2LIfT BioSciences Ltd
- Engineered natural killer cells and related methods23 Jul 2026US 2026/0209705 A1Astellas Pharma Inc.
- Tumor memory killer cell and method of producing the same2 Jul 2026US 2026/0183337 A1Dong-A University Research Foundation for Industry-Academy Cooperation
- Expansion of gamma delta t cells, compositions, and methods of use thereof25 Jun 2026US 2026/0174861 A1GammaDelta Therapeutics Ltd
Most cited
By later US patents
- Handheld electromechanical surgical system627US 10,932,784 B2Covidien LP · 2021
- Multi-chain chimeric polypeptides and uses thereof15US 11,738,052 B2HCW Biologics, Inc. · 2023
- Compositions and methods for immune cell modulation in adoptive immunotherapies5US 11,096,964 B2Fate Therapeutics, Inc. · 2021
- Method of producing natural killer cells and composition for treating cancer4US 10,590,385 B2NKMAX Co., Ltd. · 2020
- Vγ9Vδ2 T cell proliferation agent, method for producing activated Vγ9Vδ2 T cells, and uses thereof4US 7,749,760 B2Hyogo College of Medicine · 2010